REVOLUTION MEDICINES, INC. $500,000,000 SALES AGREEMENTSales Agreement • August 7th, 2024 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 7th, 2024 Company Industry Jurisdiction
REVOLUTION MEDICINES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • August 7th, 2024 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 7th, 2024 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), entered into effective as of August 1, 2024 (the “Effective Date”), is between Revolution Medicines, Inc., a Delaware corporation (the “Company”) and Jack Anders (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain Employment Agreement between Executive and the Company dated as of April 29, 2022 (the “Prior Agreement”).
SIXTH AMENDMENT TO LEASELease • August 7th, 2024 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 7th, 2024 Company IndustryThis SIXTH AMENDMENT TO LEASE (“Sixth Amendment”) is made and entered into as of July 12, 2024 (the “Effective Date”), by and between HCP LS REDWOOD CITY, LLC, a Delaware limited liability company (“Landlord”), and REVOLUTION MEDICINES, INC., a Delaware corporation (“Tenant”).